Clinical Trial: A single-center, open-label, dose-escalation, single-dose phase I clinical trial to evaluate the pharmacokinetic/pharmacodynamic (PK/PD) characteristics of NovoPhase® in healthy Chinese male participants (China)

China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A single-center, open-label, dose-escalation, single-dose phase I clinical trial to evaluate the pharmacokinetic/pharmacodynamic (PK/PD) characteristics of NovoPhase® in healthy Chinese male participants'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131571

Registration Time: 2026/09/04

Type: Interventional study

Primary Sponsor: West China Hospital of Sichuan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=340209

Published by HT Digital Content Services with permission from Health Daily Digest....